S Anuradha
.
Contact Info
Recent stories
Axis Bank scores rare success
A successful follow-on issue in India’s Axis Bank last week provided some relief to the country’s equity capital markets after a run of weak deals, even though retail investors still stayed away.
India's first REIT gets ready
Blackstone-backed Embassy Office Parks REIT is gearing up to bring India’s first REIT to market in the first quarter with an open mind to pricing in light of uncertain market conditions.
Jubilant heads to US after SGX flop
Jubilant Pharma is turning its attention to the US market after its plans for the first dual-class listing on the Singapore Exchange failed to entice investors. The drugmaker, a subsidiary of India-listed Jubilant Life Sciences, had been looking to raise up to US$500m in Singapore, but could now lead a wave of US listings from India.